京玖康疗发布中期业绩 股东应占溢利335.3万港元 同比扭亏为盈

Core Viewpoint - Jingjiu Health (00648) reported a mid-year performance for 2025, showing a revenue of HKD 35.771 million, representing a year-on-year increase of 16.5% [1] - The company achieved a profit attributable to shareholders of HKD 3.353 million, a turnaround from a loss of HKD 6.093 million in the same period last year, indicating a successful recovery [1] - Basic earnings per share were reported at HKD 0.01, reflecting the company's improved financial performance [1] Revenue Growth - The revenue growth is primarily attributed to the company's ongoing efforts to expand its product sources and broaden its product portfolio [1]